PDB Short entry for 6CCY HEADER TRANSFERASE/INHIBITOR 07-FEB-18 6CCY TITLE CRYSTAL STRUCTURE OF AKT1 IN COMPLEX WITH A SELECTIVE INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: RAC-ALPHA SERINE/THREONINE-PROTEIN KINASE,PIFTIDE; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PROTEIN KINASE B,PKB,PROTEIN KINASE B ALPHA,PKB ALPHA,PROTO- COMPND 5 ONCOGENE C-AKT,RAC-PK-ALPHA; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: AKT1, PKB, RAC; SOURCE 6 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7108 KEYWDS KINASE INHIBITOR, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR Y.WANG,S.STOUT REVDAT 2 16-MAY-18 6CCY 1 JRNL REVDAT 1 02-MAY-18 6CCY 0 JRNL AUTH S.PARTHASARATHY,K.HENRY,H.PEI,J.CLAYTON,M.REMPALA,D.JOHNS, JRNL AUTH 2 O.DE FRUTOS,P.GARCIA,C.MATEOS,S.PLEITE,Y.WANG,S.STOUT, JRNL AUTH 3 B.CONDON,S.ASHOK,Z.LU,W.EHLHARDT,T.RAUB,M.LAI,S.GEEGANAGE, JRNL AUTH 4 T.P.BURKHOLDER JRNL TITL DISCOVERY OF CHIRAL DIHYDROPYRIDOPYRIMIDINONES AS POTENT, JRNL TITL 2 SELECTIVE AND ORALLY BIOAVAILABLE INHIBITORS OF AKT. JRNL REF BIOORG. MED. CHEM. LETT. V. 28 1887 2018 JRNL REFN ESSN 1464-3405 JRNL PMID 29655979 JRNL DOI 10.1016/J.BMCL.2018.03.092 REMARK 2 REMARK 2 RESOLUTION. 2.18 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.2 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.94 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 3 NUMBER OF REFLECTIONS : 19584 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.237 REMARK 3 R VALUE (WORKING SET) : 0.235 REMARK 3 FREE R VALUE : 0.276 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.310 REMARK 3 FREE R VALUE TEST SET COUNT : 1039 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 10 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 2.18 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 2.30 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.51 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 2821 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2611 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2671 REMARK 3 BIN R VALUE (WORKING SET) : 0.2572 REMARK 3 BIN FREE R VALUE : 0.3327 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 5.32 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 150 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2653 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 41 REMARK 3 SOLVENT ATOMS : 56 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 52.25 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.86 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -11.81360 REMARK 3 B22 (A**2) : 2.24870 REMARK 3 B33 (A**2) : 9.56490 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.380 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.292 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.224 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.290 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.225 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.928 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2767 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3735 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 989 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : 68 ; 2.000 ; HARMONIC REMARK 3 GENERAL PLANES : 420 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2767 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 335 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 3188 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 1.13 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.20 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 19.88 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6CCY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 08-FEB-18. REMARK 100 THE DEPOSITION ID IS D_1000232561. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 03-FEB-12 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : APS REMARK 200 BEAMLINE : 31-ID REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97931 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARMOSAIC 225 MM CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM 7.0.5 REMARK 200 DATA SCALING SOFTWARE : SCALA 3.2.5 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19614 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.180 REMARK 200 RESOLUTION RANGE LOW (A) : 19.940 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 7.200 REMARK 200 R MERGE (I) : 0.57600 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.18 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.30 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.05 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.28 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 16% PEG 3350 AND 200MM AMMONIUM REMARK 280 FORMATE, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 24.83200 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 54.79000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.48050 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 54.79000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 24.83200 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.48050 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 PRO A 451 REMARK 465 PRO A 452 REMARK 465 ASP A 453 REMARK 465 GLN A 454 REMARK 465 ASP A 455 REMARK 465 ASP A 456 REMARK 465 SER A 457 REMARK 465 MET A 458 REMARK 465 GLU A 459 REMARK 465 CYS A 460 REMARK 465 VAL A 461 REMARK 465 ASP A 462 REMARK 465 SER A 463 REMARK 465 GLU A 464 REMARK 465 ARG A 465 REMARK 465 ARG A 466 REMARK 465 GLU A 467 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 301 CG CD CE NZ REMARK 470 ARG A 346 CG CD NE CZ NH1 NH2 REMARK 470 ARG A 367 CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 243 -53.87 70.81 REMARK 500 ARG A 273 -15.97 65.10 REMARK 500 ASP A 292 87.23 65.22 REMARK 500 ASP A 302 -151.16 60.80 REMARK 500 ASN A 324 -150.26 -73.76 REMARK 500 ASP A 398 -109.29 53.22 REMARK 500 PHE A 472 48.52 -94.45 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue EX4 A 501 DBREF 6CCY A 144 466 UNP P31749 AKT1_HUMAN 144 466 DBREF 6CCY A 467 481 UNP Q16513 PKN2_HUMAN 969 983 SEQADV 6CCY GLY A 141 UNP P31749 EXPRESSION TAG SEQADV 6CCY SER A 142 UNP P31749 EXPRESSION TAG SEQADV 6CCY LEU A 143 UNP P31749 EXPRESSION TAG SEQADV 6CCY SER A 199 UNP P31749 ASN 199 ENGINEERED MUTATION SEQADV 6CCY PRO A 396 UNP P31749 SER 396 ENGINEERED MUTATION SEQADV 6CCY SER A 397 UNP P31749 GLU 397 ENGINEERED MUTATION SEQADV 6CCY VAL A 433 UNP P31749 THR 433 ENGINEERED MUTATION SEQADV 6CCY GLU A 482 UNP Q16513 EXPRESSION TAG SEQADV 6CCY GLY A 483 UNP Q16513 EXPRESSION TAG SEQRES 1 A 343 GLY SER LEU ARG VAL THR MET ASN GLU PHE GLU TYR LEU SEQRES 2 A 343 LYS LEU LEU GLY LYS GLY THR PHE GLY LYS VAL ILE LEU SEQRES 3 A 343 VAL LYS GLU LYS ALA THR GLY ARG TYR TYR ALA MET LYS SEQRES 4 A 343 ILE LEU LYS LYS GLU VAL ILE VAL ALA LYS ASP GLU VAL SEQRES 5 A 343 ALA HIS THR LEU THR GLU SER ARG VAL LEU GLN ASN SER SEQRES 6 A 343 ARG HIS PRO PHE LEU THR ALA LEU LYS TYR SER PHE GLN SEQRES 7 A 343 THR HIS ASP ARG LEU CYS PHE VAL MET GLU TYR ALA ASN SEQRES 8 A 343 GLY GLY GLU LEU PHE PHE HIS LEU SER ARG GLU ARG VAL SEQRES 9 A 343 PHE SER GLU ASP ARG ALA ARG PHE TYR GLY ALA GLU ILE SEQRES 10 A 343 VAL SER ALA LEU ASP TYR LEU HIS SER GLU LYS ASN VAL SEQRES 11 A 343 VAL TYR ARG ASP LEU LYS LEU GLU ASN LEU MET LEU ASP SEQRES 12 A 343 LYS ASP GLY HIS ILE LYS ILE THR ASP PHE GLY LEU CYS SEQRES 13 A 343 LYS GLU GLY ILE LYS ASP GLY ALA THR MET LYS TPO PHE SEQRES 14 A 343 CYS GLY THR PRO GLU TYR LEU ALA PRO GLU VAL LEU GLU SEQRES 15 A 343 ASP ASN ASP TYR GLY ARG ALA VAL ASP TRP TRP GLY LEU SEQRES 16 A 343 GLY VAL VAL MET TYR GLU MET MET CYS GLY ARG LEU PRO SEQRES 17 A 343 PHE TYR ASN GLN ASP HIS GLU LYS LEU PHE GLU LEU ILE SEQRES 18 A 343 LEU MET GLU GLU ILE ARG PHE PRO ARG THR LEU GLY PRO SEQRES 19 A 343 GLU ALA LYS SER LEU LEU SER GLY LEU LEU LYS LYS ASP SEQRES 20 A 343 PRO LYS GLN ARG LEU GLY GLY GLY PRO SER ASP ALA LYS SEQRES 21 A 343 GLU ILE MET GLN HIS ARG PHE PHE ALA GLY ILE VAL TRP SEQRES 22 A 343 GLN HIS VAL TYR GLU LYS LYS LEU SER PRO PRO PHE LYS SEQRES 23 A 343 PRO GLN VAL THR SER GLU VAL ASP THR ARG TYR PHE ASP SEQRES 24 A 343 GLU GLU PHE THR ALA GLN MET ILE THR ILE THR PRO PRO SEQRES 25 A 343 ASP GLN ASP ASP SER MET GLU CYS VAL ASP SER GLU ARG SEQRES 26 A 343 ARG GLU GLU GLN GLU MET PHE ARG ASP PHE ASP TYR ILE SEQRES 27 A 343 ALA ASP TRP GLU GLY MODRES 6CCY TPO A 308 THR MODIFIED RESIDUE HET TPO A 308 11 HET EX4 A 501 41 HETNAM TPO PHOSPHOTHREONINE HETNAM EX4 (5R)-4-(4-{4-[4-FLUORO-3-(TRIFLUOROMETHYL)PHENYL]-1-[2- HETNAM 2 EX4 (PYRROLIDIN-1-YL)ETHYL]-1H-IMIDAZOL-2-YL}PIPERIDIN-1- HETNAM 3 EX4 YL)-5-METHYL-5,8-DIHYDROPYRIDO[2,3-D]PYRIMIDIN-7(6H)- HETNAM 4 EX4 ONE HETSYN TPO PHOSPHONOTHREONINE FORMUL 1 TPO C4 H10 N O6 P FORMUL 2 EX4 C29 H33 F4 N7 O FORMUL 3 HOH *56(H2 O) HELIX 1 AA1 THR A 146 ASN A 148 5 3 HELIX 2 AA2 LYS A 183 LYS A 189 1 7 HELIX 3 AA3 GLU A 191 SER A 205 1 15 HELIX 4 AA4 GLU A 234 ARG A 243 1 10 HELIX 5 AA5 SER A 246 GLU A 267 1 22 HELIX 6 AA6 LYS A 276 GLU A 278 5 3 HELIX 7 AA7 THR A 312 LEU A 316 5 5 HELIX 8 AA8 ALA A 317 GLU A 322 1 6 HELIX 9 AA9 ALA A 329 GLY A 345 1 17 HELIX 10 AB1 ASP A 353 GLU A 364 1 12 HELIX 11 AB2 GLY A 373 LEU A 384 1 12 HELIX 12 AB3 ASP A 398 GLN A 404 1 7 HELIX 13 AB4 HIS A 405 ALA A 409 5 5 HELIX 14 AB5 VAL A 412 GLU A 418 1 7 HELIX 15 AB6 ASP A 439 ALA A 444 1 6 SHEET 1 AA1 6 PHE A 150 LYS A 158 0 SHEET 2 AA1 6 GLY A 162 GLU A 169 -1 O VAL A 164 N GLY A 157 SHEET 3 AA1 6 TYR A 175 LYS A 182 -1 O TYR A 176 N VAL A 167 SHEET 4 AA1 6 ARG A 222 GLU A 228 -1 O LEU A 223 N LEU A 181 SHEET 5 AA1 6 LEU A 213 GLN A 218 -1 N TYR A 215 O VAL A 226 SHEET 6 AA1 6 TYR A 477 ILE A 478 -1 O TYR A 477 N SER A 216 SHEET 1 AA2 2 LEU A 280 LEU A 282 0 SHEET 2 AA2 2 ILE A 288 ILE A 290 -1 O LYS A 289 N MET A 281 LINK C LYS A 307 N TPO A 308 1555 1555 1.35 LINK C TPO A 308 N PHE A 309 1555 1555 1.35 SITE 1 AC1 19 LEU A 156 GLY A 157 GLY A 159 PHE A 161 SITE 2 AC1 19 GLY A 162 LYS A 163 VAL A 164 ALA A 177 SITE 3 AC1 19 LYS A 179 LEU A 181 THR A 211 MET A 227 SITE 4 AC1 19 GLU A 228 ALA A 230 GLU A 234 GLU A 278 SITE 5 AC1 19 MET A 281 PHE A 438 PHE A 442 CRYST1 49.664 66.961 109.580 90.00 90.00 90.00 P 21 21 21 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020135 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014934 0.000000 0.00000 SCALE3 0.000000 0.000000 0.009126 0.00000